Sartorius Stedim Biotech SA Updates on Shares and Voting Rights

Sartorius Stedim Biotech SA has made an official declaration concerning its shares and voting rights as of February 29, 2024. In compliance with the French Commercial Code (Article L 233-8-II) and the general regulations of the AMF (Autorité des marchés financiers), Article 223-6, the company has provided updated figures regarding its issued capital.

As per the statement, the total number of shares making up the issued capital as of the end of February 2024 stands at 97,330,405. Alongside this, the total number of theoretical voting rights, including treasury shares, is reported to be 165,579,858. The total number of net voting rights, a figure that excludes voting rights attached to treasury shares, amounts to 165,562,569.

This declaration by Sartorius Stedim Biotech SA is part of the company's regulatory obligations to keep its shareholders and the broader market informed of changes within its capital structure. The announcement was disseminated through EQS Group, citing the issuer’s sole responsibility for the content.